Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Döhner

Showing results (41-50 of 490) with videos related to

Pageof 49
Sort By:
Therapeutic Advances in Hematology|April 5, 2013
Targeted therapies through microRNAs: pulp or fiction?Christian Langer, Frank G Rücker, Christian Buske, et al.
Haematologica|July 29, 2010
Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantationMartin Bommer, Stephanie von Harsdorf, Hartmut Döhner, et al.
Oncology Reports|October 25, 2013
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapyAnna Babiak, Max Steinhauser, Marlies Götz, et al.
Haematologica|May 30, 2008
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemiaThorsten Zenz, Sonja Häbe, Axel Benner, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
Leukemia Research|May 4, 2004
Cross-trial networking in AML: a step forward rather than corner cuttingThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
British Journal of Haematology|June 10, 2010
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)Angela Philippen, Susanne Diener, Thorsten Zenz, et al.
Seminars in Hematology|June 23, 2017
Recognition of familial myeloid neoplasia in adultsAnna L Brown, Jane E Churpek, Luca Malcovati, et al.
Seminars in Cancer Biology|September 10, 2003
Cytogenetic evolution of follicular lymphomaAndreas a Viardot, Thomas F E Barth, Peter Möller, et al.
Haematologica|December 7, 2005
The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemiaClaudia Scholl, Richard F Schlenk, Karina Eiwen, et al.
Pageof 49

Showing results (41-50 of 490) with videos related to

Sort By:
Pageof 49
Therapeutic Advances in Hematology|April 5, 2013
Targeted therapies through microRNAs: pulp or fiction?Christian Langer, Frank G Rücker, Christian Buske, et al.
Haematologica|July 29, 2010
Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantationMartin Bommer, Stephanie von Harsdorf, Hartmut Döhner, et al.
Oncology Reports|October 25, 2013
Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapyAnna Babiak, Max Steinhauser, Marlies Götz, et al.
Haematologica|May 30, 2008
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemiaThorsten Zenz, Sonja Häbe, Axel Benner, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
Leukemia Research|May 4, 2004
Cross-trial networking in AML: a step forward rather than corner cuttingThomas Büchner, Hartmut Döhner, Gerhard Ehninger, et al.
British Journal of Haematology|June 10, 2010
SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL)Angela Philippen, Susanne Diener, Thorsten Zenz, et al.
Seminars in Hematology|June 23, 2017
Recognition of familial myeloid neoplasia in adultsAnna L Brown, Jane E Churpek, Luca Malcovati, et al.
Seminars in Cancer Biology|September 10, 2003
Cytogenetic evolution of follicular lymphomaAndreas a Viardot, Thomas F E Barth, Peter Möller, et al.
Haematologica|December 7, 2005
The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemiaClaudia Scholl, Richard F Schlenk, Karina Eiwen, et al.
Pageof 49